← Back to news

Bayer's Ambelvist (gadoquatrane) Receives FDA Approval

ICE Community ยท July 8, 2026

Bayer's Ambelvist (gadoquatrane), a contrast agent for medical imaging, has received FDA approval. The approval enables the use of this contrast media in diagnostic imaging procedures in the United States.

Read the full article on ICE Community